Liver and Biliary Pathology — MCQs

A 40-year-old diabetic female presented with fatigue, abdominal distension, pruritus, anorexia, myalgia, and skin rashes. On examination, icterus, hepatosplenomegaly, and ascites were noted. Laboratory findings included elevated SGOT/SGPT levels, IgG levels and ANA titers, hypoalbuminemia, prolonged PT, and normocytic normochromic Coombs-positive hemolytic anemia. A liver biopsy was performed. Which of the following antibodies is NOT typically seen in this condition?

Q245Medium

Liver biopsy in a patient with cirrhosis demonstrates markedly increased iron stores. The patient has no known history of hemolytic anemia or other potential causes of a secondary increase in hepatic iron stores. This patient's primary disorder is most strongly associated with which of the following HLA alleles?

Q246Easy

Honeycomb appearance of the liver is typically seen in which condition?

Q247Medium

Primary sclerosing cholangitis is likely to be associated with which of the following malignancies?

Q248Medium

Intake of which of the following causes vascular lesions in the liver?

Q249Easy

Cholangiocarcinoma has been associated with infection by which of the following organisms?

Q250Medium

A patient with cirrhosis of the liver has the following coagulation parameters: Platelet count 2,00,000, Prothrombin time 25s/12s, Activated partial thromboplastin time 60s/35s, Thrombin time 15s/15s. In this patient:

Liver and Biliary Pathology Indian Medical PG Practice Questions and MCQs

Question 241: Budd Chiari syndrome is:

A. Portal vein thrombosis
B. Hepatic artery thrombosis
C. Cystic artery thrombosis
D. Hepatic vein thrombosis (Correct Answer)

Explanation: **Explanation:** **Budd-Chiari Syndrome (BCS)** is a clinical condition caused by the obstruction of hepatic venous outflow [1]. This obstruction can occur at any level from the small hepatic veins to the junction of the inferior vena cava (IVC) with the right atrium. 1. **Why Option D is Correct:** The hallmark of Budd-Chiari syndrome is **Hepatic vein thrombosis**. When these veins are blocked, blood cannot exit the liver, leading to increased intrahepatic pressure [1]. This results in the classic clinical triad: **abdominal pain, hepatomegaly, and ascites**. Pathologically, this causes centrilobular congestion and necrosis (nutmeg liver appearance) [1]. 2. **Why Other Options are Incorrect:** * **Option A (Portal vein thrombosis):** This leads to portal hypertension and esophageal varices [2] but does not typically cause the massive hepatomegaly or centrilobular necrosis seen in BCS. * **Option B (Hepatic artery thrombosis):** This usually occurs in the context of liver transplantation and leads to biliary strictures or liver infarction [2], not venous congestion. * **Option C (Cystic artery thrombosis):** This would lead to gallbladder ischemia or gangrenous cholecystitis, unrelated to systemic hepatic venous outflow. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause:** Polycythemia vera (myeloproliferative disorders). Other causes include Factor V Leiden mutation, PNH, and pregnancy. * **Imaging Gold Standard:** Doppler Ultrasound is the initial test; Venography is the gold standard. * **Morphology:** The **Caudate lobe** is often spared and undergoes compensatory hypertrophy because it has independent venous drainage directly into the IVC. * **Microscopy:** Shows "Centrilobular congestion and sinusoidal dilatation" [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 869-870. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 868-869.

Question 242: Hepatic infarcts are seen in which of the following conditions?

A. Eclampsia
B. Chronic venous congestion
C. Budd-Chiari syndrome
D. All of the above (Correct Answer)

Explanation: The liver has a **dual blood supply** (Hepatic Artery and Portal Vein), making true hepatic infarction rare. However, infarction occurs when there is a significant compromise in blood flow or severe systemic congestion that overcomes this protective mechanism. * **Eclampsia (Option A):** In severe pre-eclampsia and eclampsia, systemic endothelial dysfunction leads to vasospasm and the formation of fibrin thrombi in the periportal sinusoids. This results in focal hemorrhage and **ischemic necrosis (infarction)**, often presenting as subcapsular hematomas [1]. * **Chronic Venous Congestion (Option B):** Prolonged right-sided heart failure causes blood to back up into the hepatic veins. This leads to "Nutmeg Liver." In severe or acute-on-chronic cases, the increased pressure and reduced arterial perfusion lead to **centrilobular hemorrhagic necrosis**, which is a form of infarction [1]. * **Budd-Chiari Syndrome (Option C):** This is characterized by the obstruction of two or more major hepatic veins. The sudden cessation of venous outflow leads to extreme intrahepatic pressure and severe congestion, resulting in **hemorrhagic infarction** of the affected liver parenchyma [1]. **Conclusion:** Since all three conditions involve mechanisms (thrombosis, congestion, or outflow obstruction) that lead to ischemic or hemorrhagic necrosis, **"All of the above"** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Zahn Infarct:** This is a "pseudo-infarct." It is a well-demarcated area of congestion and atrophy (without true necrosis) caused by the obstruction of a branch of the **portal vein**. * **Centrilobular Necrosis (Zone 3):** This area is most susceptible to ischemic injury because it is furthest from the arterial supply [1]. * **Most common cause of Hepatic Infarct:** Thrombosis or embolism of the **Hepatic Artery** (e.g., post-liver transplant or polyarteritis nodosa). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 869-872.

Question 243: A 40-year-old obese lady presents with diabetes mellitus, hypertriglyceridemia, right upper quadrant pain, and recurrent jaundice. What liver pathology is observed?

A. Nonalcoholic steatohepatitis (NASH) (Correct Answer)
B. Microvesicular hepatosis
C. Peliosis hepatis
D. Autoimmune hepatitis

Explanation: ### Explanation **Correct Option: A. Nonalcoholic steatohepatitis (NASH)** The clinical profile describes a classic case of **Metabolic Syndrome** (obesity, diabetes mellitus, and hypertriglyceridemia). NASH is the progressive form of Nonalcoholic Fatty Liver Disease (NAFLD) [2]. It occurs due to insulin resistance, which leads to increased peripheral lipolysis and hepatic uptake of free fatty acids [2]. This results in "two hits": first, hepatic steatosis, followed by oxidative stress and cytokine-mediated inflammation (steatohepatitis) [2]. Histologically, it is characterized by **macrovesicular steatosis, hepatocyte ballooning, and Mallory-Denk bodies [1].** **Why other options are incorrect:** * **B. Microvesicular hepatosis:** This is characterized by small fat droplets that do not displace the nucleus. It is typically seen in acute, life-threatening conditions like **Reye’s syndrome, Acute Fatty Liver of Pregnancy (AFLP),** or Valproate toxicity, rather than chronic metabolic syndrome. * **C. Peliosis hepatis:** This refers to the presence of blood-filled cystic spaces in the liver. It is associated with the use of **anabolic steroids, oral contraceptives,** or infections like *Bartonella henselae*. * **D. Autoimmune hepatitis:** This typically presents in young to middle-aged women with other autoimmune markers (ANA, Anti-Smooth Muscle Antibody) [5]. Histology shows a characteristic **"Interface Hepatitis"** with a dense plasma cell infiltrate, which is absent here [5]. **High-Yield Clinical Pearls for NEET-PG:** * **NAFLD** is now the most common cause of chronic liver disease worldwide [4]. * **Histological Hallmark:** The earliest sign of fibrosis in NASH is **perivenular/pericellular fibrosis** (described as a "chicken-wire" pattern) [1]. * **Mallory-Denk bodies** are eosinophilic cytoplasmic inclusions made of damaged intermediate filaments (ubiquitinated cytokeratins 8 and 18) [3]. * **ALT vs. AST:** In NASH, ALT is usually higher than AST (ALT > AST), unlike alcoholic liver disease where AST:ALT > 2:1. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 852-854. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 851-852. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 852. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389.

Question 244: A 40-year-old diabetic female presented with fatigue, abdominal distension, pruritus, anorexia, myalgia, and skin rashes. On examination, icterus, hepatosplenomegaly, and ascites were noted. Laboratory findings included elevated SGOT/SGPT levels, IgG levels and ANA titers, hypoalbuminemia, prolonged PT, and normocytic normochromic Coombs-positive hemolytic anemia. A liver biopsy was performed. Which of the following antibodies is NOT typically seen in this condition?

A. Anti-LKM 1 Ab
B. Anti-LKM 2 Ab (Correct Answer)
C. Anti-SMA
D. pANCA

Explanation: The clinical presentation—a middle-aged female with fatigue, pruritus, hepatosplenomegaly, elevated transaminases, hypergammaglobulinemia (IgG), and positive ANA—is classic for **Autoimmune Hepatitis (AIH)**. The presence of Coombs-positive hemolytic anemia further supports an autoimmune etiology. [1] **Why Anti-LKM 2 Ab is the Correct Answer:** * **Anti-LKM 2 (Liver-Kidney Microsomal type 2) antibodies** are specifically associated with **drug-induced hepatitis** (classically caused by Ticrynafen, a diuretic). They are **not** a marker for idiopathic Autoimmune Hepatitis. **Analysis of Other Options:** * **Anti-LKM 1 Ab (Option A):** These are the hallmark antibodies for **Type 2 AIH**, which typically affects children and young adults but can be seen in adults. They target Cytochrome P450 2D6. [1] * **Anti-SMA (Option C):** Anti-Smooth Muscle Antibodies are the characteristic marker for **Type 1 AIH** (the most common form worldwide), often found alongside ANA. [1] * **pANCA (Option D):** Perinuclear Anti-Neutrophil Cytoplasmic Antibodies are frequently positive in Type 1 AIH (atypical pANCA pattern), even in the absence of Primary Sclerosing Cholangitis. **Clinical Pearls for NEET-PG:** * **AIH Type 1:** Most common; ANA and/or Anti-SMA positive; associated with HLA-DR3/DR4. [1] * **AIH Type 2:** Anti-LKM 1 and/or Anti-Liver Cytosol (ALC-1) positive; usually seen in children. [1] * **AIH Type 3:** Anti-SLA/LP (Soluble Liver Antigen) positive. [1] * **Histology:** Look for **"Interface Hepatitis"** (piecemeal necrosis) and a prominent **plasma cell** infiltrate in the portal tracts. [1] * **LKM-3 Ab:** Associated with Hepatitis D (Delta) virus infection. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 845-846.

Question 245: Liver biopsy in a patient with cirrhosis demonstrates markedly increased iron stores. The patient has no known history of hemolytic anemia or other potential causes of a secondary increase in hepatic iron stores. This patient's primary disorder is most strongly associated with which of the following HLA alleles?

A. HLA-A3 (Correct Answer)
B. HLA-B27
C. HLA-DR2
D. HLA-DR3

Explanation: ### Explanation **Correct Answer: A. HLA-A3** **Concept:** The clinical presentation describes **Hereditary Hemochromatosis (HH)**, an autosomal recessive disorder characterized by excessive intestinal iron absorption leading to multiorgan deposition (cirrhosis, "bronze" diabetes, and cardiomyopathy). The most common mutation involves the **HFE gene** (C282Y mutation) located on the short arm of **Chromosome 6**. This gene is closely linked to the **HLA-A3** locus. Approximately 70% of patients with hereditary hemochromatosis carry the HLA-A3 allele, making it a classic genetic association in medical pathology. **Analysis of Incorrect Options:** * **B. HLA-B27:** Associated with **Seronegative Spondyloarthropathies**, most notably Ankylosing Spondylitis, Reactive Arthritis, and Psoriatic Arthritis [1]. * **C. HLA-DR2:** Associated with Multiple Sclerosis, Hay fever, Goodpasture syndrome, and **Narcolepsy**. * **D. HLA-DR3:** Associated with **Autoimmune disorders** such as Systemic Lupus Erythematosus (SLE), Type 1 Diabetes Mellitus, and Graves' disease [1]. **NEET-PG High-Yield Pearls:** * **Triad of Hemochromatosis:** Cirrhosis, Diabetes Mellitus, and Skin Pigmentation ("Bronze Diabetes"). * **Stain of Choice:** **Prussian Blue** (Perl’s stain) is used to visualize iron (hemosiderin) as blue granules. * **Screening:** Transferrin saturation is the best initial screening test (increased); Ferritin levels are also elevated. * **Complication:** Patients have a significantly increased risk (up to 200-fold) of developing **Hepatocellular Carcinoma (HCC)**. * **Treatment:** Therapeutic phlebotomy is the mainstay of management. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 49-50.

Question 246: Honeycomb appearance of the liver is typically seen in which condition?

A. Micronodular cirrhosis
B. Dubin Johnson's syndrome
C. Actinomycosis (Correct Answer)
D. Hydatidosis

Explanation: The **"Honeycomb appearance"** of the liver is a classic pathological description for **Hepatic Actinomycosis**. **1. Why Actinomycosis is correct:** Actinomycosis (most commonly *Actinomyces israelii*) is a chronic suppurative infection characterized by the formation of multiple communicating abscesses. These abscess cavities are separated by dense fibrous septa, creating a multiloculated, "honeycomb" architectural pattern on gross examination. Microscopically, these abscesses contain characteristic **"Sulfur granules"** (colonies of filamentous bacteria). **2. Why other options are incorrect:** * **Micronodular Cirrhosis:** Characterized by small, uniform nodules (usually <3mm) surrounded by fibrous bands [1]. It is often described as a **"Hobnail liver"** due to the irregular surface, not honeycomb. * **Dubin-Johnson Syndrome:** This is an autosomal recessive disorder of bilirubin excretion. The liver grossly appears **black or dark brown** due to the accumulation of coarse, iron-free, melanin-like pigment in hepatocytes. * **Hydatidosis (Echinococcosis):** Typically presents as a large, unilocular or multilocular cyst with a distinct wall (pericyst, ectocyst, and endocyst). While it can have "daughter cysts," it is described as a **"Water lily sign"** (on imaging) or simple cyst, not a honeycomb liver. **3. High-Yield Clinical Pearls for NEET-PG:** * **Actinomyces:** Gram-positive, non-acid-fast, anaerobic branching filaments. * **Sulfur Granules:** These are NOT made of sulfur; they are masses of bacteria with a peripheral "Splendore-Hoeppli phenomenon" (radiating eosinophilic clubs). * **Nutmeg Liver:** Seen in Chronic Passive Congestion (right heart failure) [2]. * **Frothy Liver:** Seen in *Clostridium perfringens* infection (gas gangrene) due to post-mortem gas production. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 395-396. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 870-872.

Question 247: Primary sclerosing cholangitis is likely to be associated with which of the following malignancies?

A. Adenocarcinoma of pancreas
B. Cholangiocarcinoma (Correct Answer)
C. Hepatocellular carcinoma
D. Adenocarcinoma of gallbladder

Explanation: **Explanation:** **Primary Sclerosing Cholangitis (PSC)** is a chronic cholestatic liver disease characterized by inflammation, obliterative fibrosis, and segmental narrowing of both intrahepatic and extrahepatic bile ducts [2]. **Why Cholangiocarcinoma is correct:** The chronic inflammatory state and constant biliary epithelial cell turnover in PSC significantly predispose patients to malignant transformation [1]. Approximately **10–15%** of patients with PSC will develop **cholangiocarcinoma** (bile duct cancer). This is the most feared complication of the disease, often presenting with a rapid decline in liver function or a "dominant stricture" on imaging [1]. **Analysis of Incorrect Options:** * **A. Adenocarcinoma of pancreas:** While PSC involves the biliary tree, it is not a primary risk factor for pancreatic cancer. * **C. Hepatocellular carcinoma (HCC):** HCC typically arises in the setting of cirrhosis (HBV, HCV, or Alcohol). While PSC can lead to cirrhosis, the risk of cholangiocarcinoma is disproportionately higher and more characteristic of PSC. * **D. Adenocarcinoma of gallbladder:** Although PSC patients have a slightly higher risk of gallbladder polyps and cancer, the association with cholangiocarcinoma is far more classic and frequently tested in exams. **High-Yield Clinical Pearls for NEET-PG:** * **Association:** 70–80% of PSC patients have **Ulcerative Colitis (UC)** [2]. However, only 4–5% of UC patients develop PSC [2]. * **Imaging:** The gold standard is MRCP/ERCP, showing a characteristic **"Beaded appearance"** (multifocal strictures and dilations) [2]. * **Histology:** Classic **"Onion-skin fibrosis"** (periductal concentric fibrosis) [3]. * **Antibody:** Often associated with **p-ANCA** (though not specific). * **Gender:** Predominantly affects **males** (unlike Primary Biliary Cholangitis, which affects females) [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 400-401. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 865-866. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 393-394.

Question 248: Intake of which of the following causes vascular lesions in the liver?

A. Halothanes
B. Isoniazid (INH)
C. Steroids (Correct Answer)
D. Chlorpromazine (CPZ)

Explanation: **Explanation:** The correct answer is **Steroids (C)**. Specifically, anabolic steroids and oral contraceptives are well-known causes of **Peliosis hepatis**. This is a vascular lesion characterized by the presence of blood-filled cystic spaces in the liver, which are not lined by endothelium. These cysts can rupture, leading to potentially fatal intra-abdominal hemorrhage. **Analysis of Options:** * **A. Halothanes:** Primarily cause **massive hepatic necrosis** (fulminant hepatitis). This is an immune-mediated idiosyncratic reaction leading to acute liver failure rather than a vascular lesion. * **B. Isoniazid (INH):** Causes drug-induced hepatitis ranging from asymptomatic elevation of liver enzymes to **bridging necrosis** or chronic hepatitis. It does not typically cause vascular pathology. * **D. Chlorpromazine (CPZ):** A classic cause of **intrahepatic cholestasis**. It leads to "bland cholestasis" where bile plugs are seen in canaliculi without significant inflammation or vascular damage. **High-Yield Clinical Pearls for NEET-PG:** * **Peliosis Hepatis:** Associated with **Anabolic Steroids**, Oral Contraceptive Pills (OCPs), and infections like *Bartonella henselae* (Bacillary peliosis). * **Budd-Chiari Syndrome:** Often linked to OCP use [1], leading to hepatic vein thrombosis (a different type of vascular lesion) [1]. * **Vinyl Chloride & Thorotrast:** High-yield triggers for **Angiosarcoma**, a malignant vascular tumor of the liver. * **Aflatoxin B1:** Strongly associated with **Hepatocellular Carcinoma (HCC)** via TP53 mutations. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 869-870.

Question 249: Cholangiocarcinoma has been associated with infection by which of the following organisms?

A. Paragonimus westermani
B. Clonorchis sinensis (Correct Answer)
C. Loa Loa
D. Schistosoma haematobium

Explanation: **Explanation:** **Clonorchis sinensis** (the Chinese liver fluke) is a well-established risk factor for **Cholangiocarcinoma** (adenocarcinoma of the bile duct epithelium). The pathogenesis involves the adult flukes residing in the intrahepatic bile ducts, where they cause chronic mechanical irritation and release metabolic byproducts. This leads to chronic inflammation, epithelial hyperplasia, and periductal fibrosis, eventually progressing to malignant transformation. **Analysis of Options:** * **Clonorchis sinensis (Correct):** Along with *Opisthorchis viverrini*, this parasite is classified as a Group 1 carcinogen by the IARC. It is typically acquired by consuming undercooked freshwater fish containing metacercariae. * **Paragonimus westermani:** Known as the lung fluke, it primarily causes pulmonary infections resembling tuberculosis (hemoptysis and lung cysts). It is not associated with biliary malignancy. * **Loa Loa:** A filarial nematode (African eye worm) transmitted by *Chrysops* flies. It causes Calabar swellings and subconjunctival migration but has no oncogenic potential. * **Schistosoma haematobium:** This trematode is strongly associated with **Squamous Cell Carcinoma of the Urinary Bladder**, not cholangiocarcinoma [1]. It resides in the vesical venous plexuses. **High-Yield Clinical Pearls for NEET-PG:** * **Other Risk Factors for Cholangiocarcinoma:** Primary Sclerosing Cholangitis (most common in the West), Fibropolycystic liver disease (Caroli disease), and Thorotrast exposure. * **Tumor Marker:** CA 19-9 is often elevated. * **Morphology:** Most are adenocarcinomas with abundant fibrous stroma (desmoplasia), giving them a firm, gritty consistency [2]. * **Klatskin Tumor:** A specific type of cholangiocarcinoma occurring at the junction of the right and left hepatic ducts (perihilar). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 405-408. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 880-881.

Question 250: A patient with cirrhosis of the liver has the following coagulation parameters: Platelet count 2,00,000, Prothrombin time 25s/12s, Activated partial thromboplastin time 60s/35s, Thrombin time 15s/15s. In this patient:

A. D-dimer will be normal (Correct Answer)
B. Fibrinogen will be <100 mg
C. ATIII will be high
D. Protein C will be elevated

Explanation: **Explanation:** In patients with liver cirrhosis, the liver's synthetic function is impaired, leading to a decrease in almost all coagulation factors (except Factor VIII and von Willebrand factor) [1]. This results in the prolongation of **Prothrombin Time (PT)** and **Activated Partial Thromboplastin Time (aPTT)**, as seen in this patient [2]. **1. Why Option A is Correct:** **D-dimer** is a fibrin degradation product that specifically indicates the breakdown of a cross-linked fibrin clot (fibrinolysis). In stable cirrhosis, while there is a deficiency of clotting factors, there is no active, widespread intravascular coagulation or systemic fibrinolysis occurring. Therefore, D-dimer levels remain **normal**. Elevated D-dimers would instead suggest a complication like Disseminated Intravascular Coagulation (DIC) [2]. **2. Why Incorrect Options are Wrong:** * **Option B:** While the liver synthesizes fibrinogen, levels usually remain within the normal range (200–400 mg/dL) or are only mildly decreased until the very end stages of liver failure [4]. A level <100 mg/dL is characteristic of severe DIC or afibrinogenemia [2]. * **Option C & D:** **Antithrombin III (ATIII)**, **Protein C**, and **Protein S** are natural anticoagulants synthesized by the liver [3]. In cirrhosis, their levels **decrease** alongside procoagulant factors. They will never be high or elevated in this clinical context. **Clinical Pearls for NEET-PG:** * **PT** is the most sensitive marker of liver synthetic function and is used in the **Child-Pugh** and **MELD** scores. * **Factor VII** has the shortest half-life, making PT the first lab value to become deranged in acute liver injury. * **Thrombin Time (TT)** measures the conversion of fibrinogen to fibrin; a normal TT (as seen here) confirms that fibrinogen levels and function are adequate. * **Vitamin K** administration does not fully correct the PT in cirrhosis (unlike in obstructive jaundice), as the primary issue is a lack of hepatocytes to synthesize the factors [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 582-583. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 625-626. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 624-625. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 396-398.

Practice by Chapter

Jaundice and Cholestasis

Practice Questions

Viral Hepatitis

Practice Questions

Alcoholic and Non-alcoholic Fatty Liver Disease

Practice Questions

Drug and Toxin Induced Liver Injury

Practice Questions

Cirrhosis and Its Complications

Practice Questions

Metabolic Liver Diseases

Practice Questions

Liver Tumors

Practice Questions

Gallbladder and Biliary Tract Diseases

Practice Questions

Congenital Liver Diseases

Practice Questions

Liver Transplantation Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free